glp 1 and gut microbiome Effects of GLP-1 receptor agonist on changes in the bacterium the underlying mechanisms Crosstalk between glucagon-like peptide 1

T2D independently elevates colorectal cancer risk, though the cumulative impact of both conditions had not previously been studied at scale

This cautious approach can be attributed to the historical context of Rimonabant, a previously promising anti-obesity agent withdrawn from the market in 2008 due to severe psychiatric side effects 26

Enthesopathies and enthesitis

The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities for better health for our patients with obesity and diabetes, said Deborah Horn, DO, MPH, professor and director of obesity medicine at McGovern Medical School at UTHealth Houston and principal author of the study

Combined, these actions help manage appetite and blood sugar levels